Recent

% | $
Quotes you view appear here for quick access.

American Capital Agency Corp. Message Board

gene4346 186 posts  |  Last Activity: 4 hours ago Member since: Dec 21, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • ....especially the second to last sentence says it all.....read it and weep shortie..
    CNA Finance - Aug 24, 2015
    Galena Biopharma is having an incredible day in the market today. Not only is the market working to bounce back from Friday’s crash, but the company also released data with regard to a recommendation that seems to have investors incredibly excited. Galena Biopharma is a company that’s focused on developing and commercializing innovative, targeted oncology therapeutics across a wide spectrum of cancer indications. The company announced today that the Independent Data Monitoring Committee has sent a recommendation to the company that GALE work to reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 study. The IDMC stated that a reduction in cardiac toxicity monitoring is justified and consistent with pre-specified Cardiac Toxicity Monitoring Stopping Rules defined in the study’s protocol. This proved to be the only suggestion from IDMC surrounding the trial, insinuating that the trial is going incredibly well. Not only is the stock bouncing back from Friday’s declines, investors are excited about the insinuation that the Phase 3 study is going well. Currently (1:37), GALE is trading at $1.51 per share after a gain of 12.69% so far today. Moving forward, I’m expecting to see a continuation of bullish activity. The reality is that the recommendation from the IDMC surrounding the company’s phase 3 trial insinuates that the trial is going well. From that, we can gather that when data is released, it is likely going to be positive data that acts as a catalyst for the stock sending the price higher. Considering the assumption that the Phase 3 trial is going well, we can also assume that the next step will be a New Drug Application with the FDA followed by approval. If that is indeed the case, GALE will finally be put on the map as one of the several stocks in biotech that has an approved product, ultimately leading to more incredible gains.

    Sentiment: Buy

  • Davis Votes to Modernize Our Health Care Infrastructure, Accelerate Approval Process for New Cures
    Washington, Jul 10

    U.S. Rep. Rodney Davis (R-Ill.) today released the following statement after the House overwhelmingly passed H.R. 6, the 21st Century Cures Act, by a vote of 344-77. Davis was an early cosponsor of this bipartisan bill to modernize our health care infrastructure and accelerate the approval process for new drug development, medical devices, and other treatments.

    “Today, it takes an average of 15 years to move a drug from the lab to our local pharmacies,” said Davis. “And like too many of my constituents, my family has been impacted by illness, both successful and unsuccessful battles with cancer, so if we can speed up this process by even just one year by cutting through bureaucratic red tape, we must do so. I came to Congress to make Washington work for the people I serve and today I’m proud the House took the lead on a bipartisan bill that could save millions and help so many others live longer, healthier lives.”

    The 21st Century Cures Act makes the following improvements to our innovative health care infrastructure:

    • Removes regulatory uncertainty for the development of new medical apps;
    • Modernizes clinical trials;
    • Provides incentives for developing drugs to fight rare diseases;
    • Removes barriers to improving and increasing research capabilities;
    • Improving coordination with the entire biomedical system to find cures more quickly;
    • Makes investments in 21st century science; and
    • Implements long-term reforms that will reduce the deficit by $500 million over the next 10 years and an additional $7 billion the following decade.

    Sentiment: Buy

  • A company with 2 FDA approved drugs on the market, a potential blockbuster in Phase3 and 2 others in Phase 2 and we're tanking down to $1.50....................Clearly the shorts and MM's are in control and all we can do is sit by and watch......this really sucks.................

    Sentiment: Buy

  • ......is the following statement - "Even if you are on the sidelines and Galena shoots higher on positive data you'll be able to buy in and benefit from potential partnerships, the development of GALE-301 or GALE-401, and the actual sales of NeuVax if it's approved. Missing one binary event doesn't mean you'll miss the boat on Galena, which makes hanging out on the sidelines a potentially smart idea."

    That's not how it works. If you are sitting on the sidelines when a major announcement is made you will miss "the big jump". In this biotech stock game, you need to be proactive, not reactive because you will always be reacting to what happened yesterday and never catch that rabbit. If there is a buyout, drug approval, etc.....and they halt trading, then what are you going to do while you are "sitting on the sidelines", play with your d$ck?

    Sentiment: Strong Buy

  • ....should be tied directly to performance (pps); it's just that simple IMHO. Pay them all a "fair" and competitive salary, and tie the stock options/bonuses to achieving certain "financial" measurable milestones that will result in increased pps...i.e. attaining Abstral sales goals, on-time Zuplenz launch and attaining sales levels, successful completion of various Clinical Trial Phases, etc....Why provide them with "Get Out Of Jail Free" cards with no strings attached to it (regardless of company performance), while we sit here at the edges of our seats every day "hoping" for a break?

    Sentiment: Buy

  • How predictable he has become in timing, message/theme and, of course, accuracy. Once again he must not have proofed his article. As you can see he refers to Maxim's "2023" price target of $7.00....what a loser....."With Galena valued at just $1.42 per share, Maxim Group released a very bullish report on Galena, claiming the stock was a "buy" and its 2023 price target, using a combination of free cash flow for the firm, discounted EPS, and a "sum-of-the-parts modeled with a 30% discount rate," came out to $7 per share."

    Sentiment: Strong Buy

  • I continue to be long and feel GALE has a very bright future, but my patience is wearing thin and I am tired of the MM's, shorts, bashers, etc....manipulating the price and this never-ending roller coaster ride. Trust me, with the large number of shares I currently own, I would not live that much better on $20 per share down the road than I would on $10 per share today, plus I wouldn't have all this day-in / day-out BS to contend with. I have absolutely NO intentions of selling now so no one is going to get my shares, but a Buyout at $10 would be just fine with me.................

    Sentiment: Strong Buy

  • Reply to

    Good news for all long! GALE301 FDA approval

    by anita_chen38 Jul 14, 2015 3:50 PM
    gene4346 gene4346 Jul 14, 2015 4:02 PM Flag

    If you were truly a long you would have supplied your source. For the sake of us "real" longs, please do not stoop to basher's level and spread rumors.....take the high road...good news or bad news and stick with the truth......

    Sentiment: Buy

  • Go to their website and check-out "Staff" and "Clinical Trials" tabs.........VERY interesting.........

    Sentiment: Buy

  • gene4346 gene4346 Jul 19, 2015 8:32 AM Flag

    Well said and I feel exactly the same. In the case, "the longer the wait ...the better the news"......

    Sentiment: Buy

  • Several other small biotechs are climbing by dollars because they are making things happen and we are dickin' around with pennies.....

    Sentiment: Strong Buy

  • Reply to

    Where's DanInDenver?

    by bholbr1042 Jun 4, 2015 4:03 PM
    gene4346 gene4346 Jun 4, 2015 6:30 PM Flag

    Welcome back Dan (seriously). I, for one, have missed your intelligent and fact-based comments, insight and fortitude. GLT to you and all longs.................

    Sentiment: Strong Buy

  • Reply to

    It's Been a Rocky Road

    by our_politicians_suck Jun 13, 2015 7:50 AM
    gene4346 gene4346 Jun 13, 2015 8:38 AM Flag

    OPS.....thank you for that post. I vented my frustration on this MB yesterday and I feel I am entitled to that, but it is refreshing to read an honest, objective and positive post such as yours today to help put things back into perspective. Have a great weekend and hold, hold, hold..................

    Sentiment: Strong Buy

  • Reply to

    I Am Long, BUT....Mgmt & BOD Incentive Plan.....

    by gene4346 Jun 25, 2015 12:30 PM
    gene4346 gene4346 Jun 25, 2015 12:51 PM Flag

    But my point is - where is the "incentive" to make them work harder and "drive" the business? It just appears there are no consequences when they miss a goal/number, target day, etc.....it's just..."oh well, just push it out into the future and hopefully we'll hit it next".......

    Sentiment: Buy

  • ........Are you blind or just plain stupid. He is NOT pro-GALE - can't you read between the lines? If you can't read between the lines, maybe you will understand his statement - "Until we have data from Galena's planned interim analysis of PRESENT, it's probably not in your best interest to gamble your money in owning Galena's shares." How can some of you more intelligent (or at least I thought you were intelligent) buy his B$S.........Get your head out of the sand or whatever orifice in your body you have it stuck in..............

    Sentiment: Buy

  • gene4346 gene4346 Jun 30, 2015 1:54 PM Flag

    Got it right.......are you crazy Dan? What part of his statement "Until we have data from Galena's planned interim analysis of PRESENT, it's probably not in your best interest to gamble your money in owning Galena's shares." is getting it right?

    Sentiment: Buy

  • Reply to

    Lawsuit Update

    by rocketjock1 Aug 7, 2015 3:28 PM
    gene4346 gene4346 Aug 7, 2015 7:30 PM Flag

    If it's not ALL good news, then it's bad news and we (shareholders) will pay the price (again) in the form of lower PPS because of management's greed. This will continue to be an ugly cloud hanging over GALE and scare away any potential partners....and once again.....we (shareholders) will pay the price because of management's greed. This band of thieves has cost me a lot of money and I have zero trust in them.....just being honest.......

    Sentiment: Buy

  • Reply to

    Biggest take from this morning's PR

    by highflier2go Aug 24, 2015 6:12 PM
    gene4346 gene4346 Aug 24, 2015 6:14 PM Flag

    Good point............and that means good trial...........and that means good news.......$$$$$$$$$

    Sentiment: Buy

  • gene4346 gene4346 Aug 29, 2015 1:56 PM Flag

    I just sent an email to the conference coordinator and asked if a copy / link to Dr. M's presentation is available. I will post any comments if I get a response. FYI................

    Sentiment: Buy

  • ....on 7K shares.....no problem.....tomorrow we move above $2 and never look back...........GLTA longs..........and hold, hold, hold those shares....

    Sentiment: Buy

AGNC
19.36-0.19(-0.97%)Aug 28 4:00 PMEDT